Exercise on Compounded Semaglutide: Best Practices

Published May 25, 2026Updated May 27, 2026Last reviewed May 25, 2026

For the broader cluster context, see the semaglutide lifestyle and adherence hub.

Author: HealthRX Editorial Team Medically reviewed by: Dr. Mark Halpern, MD (Internal Medicine, Obesity Medicine) Last clinical review: May 2026

Compounded semaglutide is not FDA-approved. This article is patient education and does not replace consultation with a licensed clinician.

Rachel, 41, from Scottsdale, told her clinician in February that she'd lost 22 pounds in three months on compounded semaglutide but felt "soft, like I was deflating instead of shrinking." Her body fat percentage hadn't budged. She was walking four days a week, eating around 1,200 calories, and doing zero resistance training. Her prescriber added three 30-minute resistance sessions per week and bumped her protein to 100 grams a day. Six weeks later she'd lost another 8 pounds, but the real shift was in the mirror: her arms looked different, her back looked different, and her resting heart rate dropped from 78 to 68. "I wish someone had told me the weight loss part was the easy part," she said. "The exercise part is what made it feel like it was actually working."

That tracks with what the clinical data show. And it's the core argument of this article: the medication handles the caloric reduction, but exercise determines the quality of what you lose and whether you keep the results.

This guide sits inside the broader Semaglutide Lifestyle and Adherence cluster, which is part of the compounded semaglutide pillar guide.

The Medication Reduces Calories. Exercise Decides Everything Else.

Here's the thing about semaglutide: it's extraordinarily good at one job. It suppresses appetite, slows gastric emptying, and produces a sustained caloric deficit that most people couldn't maintain through willpower alone. The STEP-1 trial showed a mean weight loss of about 15% of body weight at 68 weeks. That's the medication doing its work.

But "weight loss" is a blunt instrument. Lose 30 pounds and 8 of those pounds might be lean tissue (muscle, bone density contribution, metabolically active mass). Lose those same 30 pounds while resistance training and eating adequate protein, and you can cut that lean tissue loss dramatically. The body doesn't care about the number on the scale. It cares about what's left when the fat is gone.

STEP-3 paired semaglutide with a structured lifestyle intervention that included a daily 30-minute activity prescription and intensive behavioral counseling. The result: greater mean weight loss than STEP-1, which used the medication alone. The most straightforward reading of that data is that lifestyle is additive. Not optional. Additive.

Compounded semaglutide uses the same active ingredient as Wegovy and Ozempic, prepared by a licensed compounding pharmacy under clinician prescription. It is not FDA-approved, and has not been independently tested in randomized trials at the same scale. But the molecule is the same molecule, and the exercise principles apply regardless of preparation.

Resistance Training Is Not Optional (It's the Whole Point)

I'll put this bluntly: if you're on semaglutide of any kind and you're not doing some form of resistance training, you are leaving the most important part of the protocol on the table.

A caloric deficit without resistance training is a lean-mass blender. Your body burns fat, yes, but it also breaks down muscle for energy. On semaglutide, where caloric intake can drop significantly (some patients report eating 800 to 1,100 calories per day in the first weeks, often unintentionally), the risk of muscle loss is real.

Resistance training signals the body to preserve muscle. It doesn't need to be complicated. Three sessions per week, targeting major muscle groups, at a load that feels challenging by the last few reps. Bodyweight squats, dumbbell rows, push-ups, lunges. A gym membership helps but isn't required. Most obesity medicine clinicians treating GLP-1 patients converge on three resistance sessions per week as a floor, not a ceiling.

Two practical problems show up in the first eight weeks of therapy. First, you have less caloric fuel available for hard training. Sessions will feel harder than they did before. That's not a sign to stop; it's a sign to manage intensity, rest between sets, and prioritize protein within an hour post-workout. Second, dehydration sneaks up on people. You're eating less food, and food carries water. Combine that with exercise-induced sweat loss and you get headaches, dizziness, and fatigue that patients sometimes blame on the medication when the real culprit is a 40-ounce daily water deficit.

Cardio Still Matters, but the Ratio Shifts

The standard recommendation for adults on semaglutide therapy is 150 to 300 minutes per week of moderate-intensity aerobic activity, adjusted for fitness level and any clinical limitations. Walking counts. Swimming counts. A spin class counts.

But here's where the conventional wisdom (cardio for weight loss!) collides with the reality of GLP-1 therapy. The medication is already handling the caloric deficit. You don't need to burn 500 calories on a treadmill to create one. That changes the calculus. Cardio on semaglutide is primarily about cardiovascular fitness, metabolic health markers, mood, and behavioral consistency, not about burning calories.

The SELECT trial showed cardiovascular benefit from semaglutide independent of weight loss, so the cardiometabolic case for staying active is strong regardless. But if you have three hours per week for exercise (and most people do, give or take), splitting that into two hours of resistance and one hour of cardio will produce better body composition outcomes than the reverse. This is probably the single most underappreciated point in exercise on compounded semaglutide best practices.

Plateaus Are Normal. Your First Move Isn't a Dose Change.

A plateau, clinically speaking, is three or more weeks without meaningful scale change during active therapy. It feels like the medication stopped working. It almost certainly didn't.

What happened is your body reached a new equilibrium. At your current intake and activity level, you're burning roughly what you're consuming. The medication is still suppressing appetite and slowing gastric emptying. Your metabolism adjusted. This is physiology doing exactly what physiology does.

The first interventions for a plateau are almost always lifestyle-based:

Audit protein. Many patients drift below 0.7 grams per pound of body weight. Small increases in protein (even 20 grams per day) can restart composition change without adding much total calorie load.
Add or intensify resistance training. If you're doing two sessions, go to three. If you're using 10-pound dumbbells and they've gotten easy, go to 15.
Check sleep. Inadequate sleep is correlated with poorer weight loss outcomes in observational data. It also tanks your recovery, your willpower, and your appetite regulation through pathways that have nothing to do with GLP-1 signaling.
Recalibrate portions. Appetites partly normalize over time on therapy. Some patients find they're eating more at month four than month two without realizing it.

If lifestyle review doesn't budge a plateau over six to eight weeks at a stable dose, then the prescribing clinician may discuss dose adjustments. That's a clinical decision made with your prescriber. Not a Reddit decision. Not a self-titration decision.

Some apparent plateaus aren't even real. Daily weight fluctuates one to three pounds from water balance, glycogen storage, hormonal cycles, sodium intake, and bowel patterns. A single weigh-in on a bad day can look like stalling when the monthly trend is still clearly downward. Weekly weigh-ins averaged over four weeks give you a much more honest signal.

What Happens When People Stop Moving (and Stop the Medication)

STEP-4 is the trial that keeps obesity medicine clinicians up at night. Patients were given semaglutide for 20 weeks, then randomized to either continue the drug or switch to placebo. The placebo group regained a significant portion of their lost weight over the following 48 weeks.

This surprises no one who treats obesity as a chronic condition, which it is. The biology of weight regulation reasserts itself when pharmacologic support is removed, the same way blood pressure climbs back up when you stop an antihypertensive. The interesting question isn't whether regain happens (it does). The question is whether patients who built strong exercise and nutrition habits during active therapy have a better trajectory post-medication than those who relied on the drug alone.

We don't have a large, clean randomized trial answering that question specifically. But the clinical logic is strong, and it aligns with decades of weight maintenance research pre-GLP-1: people who exercise regularly and eat adequate protein maintain more of their loss over time than people who don't. Semaglutide doesn't change that principle. If anything, it gives you a window to build those habits while appetite suppression makes them easier to establish.

Four Things Patients Get Wrong

1. "Compounded semaglutide is the same as Wegovy." Same active ingredient. Different regulatory status. Compounding pharmacies operate under a different framework (503A or 503B), with different oversight. Compounded preparations are not FDA-approved.

2. "Worse side effects mean the drug is working harder." Trial data from STEP-1 and STEP-3 don't support this. Some patients with minimal GI side effects achieve excellent weight loss. Some patients with significant nausea lose the same amount. Side effect severity is not a proxy for efficacy.

3. "I don't need to exercise because the medication handles it." STEP-3 (medication plus lifestyle) beat STEP-1 (medication alone). Exercise is additive. Period.

4. "Once I hit my goal weight, I can stop everything." STEP-4 documented partial regain after drug withdrawal. The chronic biology of weight regulation doesn't take a vacation because you reached a number on the scale.

Adjacent Reading

Where This Fits

This article is part of the Semaglutide Lifestyle and Adherence cluster. For a broader treatment of the molecule, the regulatory pathway, the 503A and 503B compounding framework, and the clinical evidence base, the compounded semaglutide pillar guide is the primary reference on this site.

Frequently Asked Questions

Does exercise affect weight loss results on semaglutide?

Yes. Resistance training during weight loss helps preserve lean mass, and STEP-3 (which combined semaglutide with a structured lifestyle intervention including activity) produced higher total weight loss than the medication-only arm in STEP-1. The effect is both compositional and quantitative.

What counts as a weight loss plateau on semaglutide?

Three or more weeks without meaningful scale change during active therapy. Plateaus are a normal part of the process and usually reflect a new caloric equilibrium at your current intake and activity level, not a failure of the medication.

Does sleep actually matter for weight loss on semaglutide?

It matters a lot. Sleep affects appetite-regulating hormones, glycemic regulation, recovery from exercise, and behavioral adherence. Inadequate sleep is consistently correlated with poorer weight loss outcomes in observational studies.

Should I exercise differently on injection day?

Most clinicians don't restrict exercise on injection day, but many patients prefer lighter activity (a walk, yoga, stretching) within 12 to 24 hours of their injection, especially if they experience GI side effects. Listen to your body, and discuss timing preferences with your prescriber.

How much protein do I need while exercising on semaglutide?

Most obesity medicine references recommend 0.7 to 1.0 grams of protein per pound of body weight during active weight loss with resistance training. When caloric intake is reduced by the medication, hitting this target requires deliberate planning. Protein should be a priority at every meal.

Can I do high-intensity training on semaglutide?

You can, but expect it to feel harder, especially in the first few months when caloric intake drops most sharply. Stay hydrated, manage intensity, and ensure adequate pre- and post-workout nutrition. If you feel dizzy or faint during high-intensity sessions, back off and talk to your clinician.

Is the exercise advice different for compounded semaglutide versus brand-name?

No. The active ingredient is the same. Exercise recommendations apply to the molecule, not the preparation. The regulatory status of compounded semaglutide (not FDA-approved) is distinct from Wegovy and Ozempic, but the physiology of exercise during GLP-1 therapy doesn't change based on how the drug was prepared.

Compliance and Authorship

This article references the STEP-1, STEP-3, STEP-4, SUSTAIN, SELECT, and LEADER clinical trial programs where appropriate. It is intended as patient education and does not replace consultation with a licensed clinician.